Vincent T. DeVita
Vincent T. DeVita
Vincent T. DeVita Jr. is an American oncologist and researcher known for his significant contributions to the field of oncology. He has made substantial advancements in cancer research and treatment throughout his career.
Early Life and Education[edit | edit source]
Vincent T. DeVita was born on March 7, 1935, in New York City, New York. He attended the University of Pennsylvania, where he earned his Bachelor of Science degree. He later pursued his medical degree at the University of Pennsylvania School of Medicine.
Career[edit | edit source]
DeVita's career in oncology began at the National Cancer Institute (NCI), where he conducted groundbreaking research on chemotherapy treatments for various types of cancer. He later served as the director of the NCI and played a pivotal role in shaping cancer research initiatives at the national level.
DeVita also served as the physician-in-chief at Memorial Sloan Kettering Cancer Center in New York City, where he continued to advance the field of oncology through his research and clinical practice.
Contributions to Oncology[edit | edit source]
Throughout his career, DeVita has been a leading figure in the development of combination chemotherapy regimens for cancer treatment. His work has significantly improved survival rates and quality of life for cancer patients.
DeVita is also known for his advocacy for cancer research funding and public awareness of the importance of early detection and treatment.
Awards and Recognition[edit | edit source]
DeVita's contributions to oncology have been widely recognized, and he has received numerous awards and honors for his work. He is a member of several prestigious medical societies and has been elected to the National Academy of Sciences.
Legacy[edit | edit source]
Vincent T. DeVita's legacy in the field of oncology continues to inspire future generations of researchers and clinicians to strive for excellence in cancer care and research.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
